Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

7 REITs to Buy if You’re Confident About the Economic Recovery

By Josh Enomoto, InvestorPlace Contributor

If you believe in the economy’s bullish trajectory but are looking for a more balanced approach to the market, consider these REITs.

7 Defense Stocks to Buy as a Hedge Against Global Tensions

By Josh Enomoto, InvestorPlace Contributor

The defense industry will always be relevant as turmoil remains constant worldwide, so these seven defense stocks can offer consistency.

Should You Swing for the Fences with Exela Technologies?

By Josh Enomoto, InvestorPlace Contributor

While XELA stock might appeal to speculators because of its high short interest, interested buyers should consider the bigger picture.

7 Reddit Penny Stocks That Are Lighting Up the Internet and the Market

By Josh Enomoto, InvestorPlace Contributor

Penny stocks are as speculative as investments get, but if you don't mind the risk involved, these seven offer reasons to be interested.

The Delta Variant Gives Novavax an Outside Chance of Upside

By Josh Enomoto, InvestorPlace Contributor

With the worsening Covid-19 crisis, NVAX stock offers relevance in the international market but you should remain vigilant.

Lingering Doubts About the Pandemic Makes Airbnb a Mighty Tough Choice

By Josh Enomoto, InvestorPlace Contributor

With so many unknowns related to the Covid-19 crisis, you shouldn’t touch ABNB stock unless you’re confident about its trajectory.

Clover Health Investments Stock Is a Gamble on Two Different Fronts

By Josh Enomoto, InvestorPlace Contributor

Struggling CLOV stock suddenly got a Q2 earnings reprieve but investors should think carefully before riding this momentum.

7 Telecom Stocks to Buy to Dial Out Market Anxiety

By Josh Enomoto, InvestorPlace Contributor

With a low-interest rate environment and uncertainty about what lies next, telecom stocks offer a reasonably reliable opportunity.

The Crypto Recovery Might Be Bad News for GameStop

By Josh Enomoto, InvestorPlace Contributor

Although you can never count out GME stock, the recent rise of other speculative assets might compete for attention.

As Insiders Bail on Palantir Technologies Stock, Don’t Get Caught Holding the Bag

By Josh Enomoto, InvestorPlace Contributor

While PLTR stock appears like an enormously relevant investment, that key insiders apparently don’t believe so is troubling.

Load More